Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
64
EMR Quote, Financials, Valuation and Earnings
Last price:
$147.55
Seasonality move
:
1.73%
Day range:
$154.50 - $165.15
52-week range:
$90.06 - $165.15
Dividend yield:
1.38%
P/E ratio:
37.78x
P/S ratio:
4.81x
P/B ratio:
4.29x
Volume:
7.6M
Avg. volume:
3.6M
1-year change:
21.87%
Market cap:
$86.9B
Revenue:
$18B
EPS (TTM):
$4.09
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $18.2B | $13.8B | $15.2B | $17.5B | $18B | |
| Revenue Growth (YoY) | 8.59% | -24.28% | 9.87% | 15.32% | 2.97% | |
| Cost of Revenues | $11B | $7.9B | $8.3B | $9.7B | $9.4B | |
| Gross Profit | $7.2B | $5.9B | $6.9B | $7.8B | $8.6B | |
| Gross Profit Margin | 39.59% | 42.95% | 45.5% | 44.58% | 47.91% | |
| R&D Expenses | $485M | $385M | $523M | $781M | $771M | |
| Selling, General & Admin | $4.2B | $3.6B | $4.2B | $5.1B | $5.1B | |
| Other Inc / (Exp) | -$42M | $270M | $137M | -$557M | -- | |
| Operating Expenses | $4.2B | $3.6B | $4.2B | $5.1B | $5.1B | |
| Operating Income | $3B | $2.3B | $2.7B | $2.7B | $3.5B | |
| Net Interest Expenses | $166M | $228M | $261M | $323M | $387M | |
| EBT. Incl. Unusual Items | $2.9B | $2.4B | $2.7B | $2B | $2.9B | |
| Earnings of Discontinued Ops. | -- | $1.3B | $11.1B | $350M | $8M | |
| Income Tax Expense | $585M | $549M | $599M | $415M | $696M | |
| Net Income to Company | $2.3B | $3.2B | $13.2B | $2B | $2.2B | |
| Minority Interest in Earnings | $24M | -$1M | -$25M | -$13M | -$47M | |
| Net Income to Common Excl Extra Items | $2.3B | $1.9B | $2.1B | $1.6B | $2.2B | |
| Basic EPS (Cont. Ops) | $3.85 | $4.63 | $3.75 | $3.44 | $4.07 | |
| Diluted EPS (Cont. Ops) | $3.83 | $4.60 | $3.73 | $3.43 | $4.05 | |
| Weighted Average Basic Share | $598.1M | $592.9M | $574.2M | $571.3M | $564M | |
| Weighted Average Diluted Share | $601.8M | $596.3M | $577.3M | $574M | $566.7M | |
| EBITDA | $4B | $3.2B | $3.8B | $4.3B | $5B | |
| EBIT | $3B | $2.3B | $2.7B | $2.7B | $3.5B | |
| Revenue (Reported) | $18.2B | $13.8B | $15.2B | $17.5B | $18B | |
| Operating Income (Reported) | $3B | $2.3B | $2.7B | $2.7B | $3.5B | |
| Operating Income (Adjusted) | $3B | $2.3B | $2.7B | $2.7B | $3.5B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.2B | $3.4B | $4.1B | $4.2B | $4.3B | |
| Revenue Growth (YoY) | -24.16% | 6.94% | 22.02% | 1.39% | 4.1% | |
| Cost of Revenues | $1.8B | $1.9B | $2.5B | $2.2B | $2.2B | |
| Gross Profit | $1.3B | $1.5B | $1.6B | $2B | $2.1B | |
| Gross Profit Margin | 42.73% | 44.55% | 39.96% | 48.04% | 48.56% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $849M | $1B | $1.3B | $1.2B | $1.2B | |
| Other Inc / (Exp) | $446M | -$2M | -$177M | $1M | -- | |
| Operating Expenses | $848M | $1B | $1.3B | $1.2B | $1.2B | |
| Operating Income | $500M | $474M | $368M | $781M | $868M | |
| Net Interest Expenses | $42M | $68M | $84M | $52M | $116M | |
| EBT. Incl. Unusual Items | $942M | $422M | $175M | $775M | $775M | |
| Earnings of Discontinued Ops. | $149M | $2B | -$27M | -- | -- | |
| Income Tax Expense | $196M | $98M | $16M | $182M | $169M | |
| Net Income to Company | $895M | $2.3B | $132M | $593M | $606M | |
| Minority Interest in Earnings | -$1M | -$5M | -$10M | $8M | $1M | |
| Net Income to Common Excl Extra Items | $746M | $324M | $159M | $593M | $606M | |
| Basic EPS (Cont. Ops) | $1.25 | $0.56 | $0.25 | $1.03 | $1.08 | |
| Diluted EPS (Cont. Ops) | $1.25 | $0.56 | $0.25 | $1.02 | $1.07 | |
| Weighted Average Basic Share | $594.6M | $583.6M | $570.8M | $568.5M | $561.8M | |
| Weighted Average Diluted Share | $598.1M | $586.7M | $573.3M | $571.1M | $564.1M | |
| EBITDA | $678M | $734M | $790M | $1.2B | $1.2B | |
| EBIT | $500M | $474M | $368M | $781M | $868M | |
| Revenue (Reported) | $3.2B | $3.4B | $4.1B | $4.2B | $4.3B | |
| Operating Income (Reported) | $500M | $474M | $368M | $781M | $868M | |
| Operating Income (Adjusted) | $500M | $474M | $368M | $781M | $868M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $17.2B | $14B | $15.9B | $17.5B | $18.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $10.3B | $7.9B | $8.9B | $9.4B | $9.4B | |
| Gross Profit | $6.9B | $6.1B | $7B | $8.2B | $8.7B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $4B | $3.8B | $4.4B | $5.1B | $5.1B | |
| Other Inc / (Exp) | $448M | -$204M | -$38M | -$379M | -- | |
| Operating Expenses | $4B | $3.8B | $4.4B | $5.1B | $5.1B | |
| Operating Income | $2.9B | $2.3B | $2.6B | $3.1B | $3.6B | |
| Net Interest Expenses | $166M | $254M | $277M | $309M | $450M | |
| EBT. Incl. Unusual Items | $3.3B | $1.9B | $2.5B | $2.6B | $2.9B | |
| Earnings of Discontinued Ops. | $149M | $3.2B | $9B | $377M | $7M | |
| Income Tax Expense | $670M | $451M | $527M | $581M | $682M | |
| Net Income to Company | $2.8B | $4.7B | $11B | $2.4B | $2.3B | |
| Minority Interest in Earnings | $16M | -$5M | -$24M | $5M | -$54M | |
| Net Income to Common Excl Extra Items | $2.6B | $1.5B | $2B | $2B | $2.3B | |
| Basic EPS (Cont. Ops) | $4.36 | $2.49 | $3.53 | $4.22 | $4.11 | |
| Diluted EPS (Cont. Ops) | $4.34 | $2.47 | $3.51 | $4.20 | $4.09 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $3.8B | $3.2B | $3.8B | $4.7B | $5.1B | |
| EBIT | $2.9B | $2.3B | $2.6B | $3.1B | $3.6B | |
| Revenue (Reported) | $17.2B | $14B | $15.9B | $17.5B | $18.2B | |
| Operating Income (Reported) | $2.9B | $2.3B | $2.6B | $3.1B | $3.6B | |
| Operating Income (Adjusted) | $2.9B | $2.3B | $2.6B | $3.1B | $3.6B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.2B | $3.4B | $4.1B | $4.2B | $4.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.8B | $1.9B | $2.5B | $2.2B | $2.2B | |
| Gross Profit | $1.3B | $1.5B | $1.6B | $2B | $2.1B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $849M | $1B | $1.3B | $1.2B | $1.2B | |
| Other Inc / (Exp) | $446M | -$2M | -$177M | $1M | -- | |
| Operating Expenses | $848M | $1B | $1.3B | $1.2B | $1.2B | |
| Operating Income | $500M | $474M | $368M | $781M | $868M | |
| Net Interest Expenses | $42M | $68M | $84M | $52M | $116M | |
| EBT. Incl. Unusual Items | $942M | $422M | $175M | $775M | $775M | |
| Earnings of Discontinued Ops. | $149M | $2B | -$27M | -- | -- | |
| Income Tax Expense | $196M | $98M | $16M | $182M | $169M | |
| Net Income to Company | $895M | $2.3B | $132M | $593M | $606M | |
| Minority Interest in Earnings | -$1M | -$5M | -$10M | $8M | $1M | |
| Net Income to Common Excl Extra Items | $746M | $324M | $159M | $593M | $606M | |
| Basic EPS (Cont. Ops) | $1.25 | $0.56 | $0.25 | $1.03 | $1.08 | |
| Diluted EPS (Cont. Ops) | $1.25 | $0.56 | $0.25 | $1.02 | $1.07 | |
| Weighted Average Basic Share | $594.6M | $583.6M | $570.8M | $568.5M | $561.8M | |
| Weighted Average Diluted Share | $598.1M | $586.7M | $573.3M | $571.1M | $564.1M | |
| EBITDA | $678M | $734M | $790M | $1.2B | $1.2B | |
| EBIT | $500M | $474M | $368M | $781M | $868M | |
| Revenue (Reported) | $3.2B | $3.4B | $4.1B | $4.2B | $4.3B | |
| Operating Income (Reported) | $500M | $474M | $368M | $781M | $868M | |
| Operating Income (Adjusted) | $500M | $474M | $368M | $781M | $868M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.4B | $1.8B | $8.1B | $3.6B | $1.5B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $3.5B | $2.3B | $2.5B | $2.9B | $3.1B | |
| Inventory | $2.1B | $1.7B | $2B | $2.2B | $2.2B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1.1B | $1.3B | $1.2B | $1.5B | -- | |
| Total Current Assets | $8.4B | $8.5B | $13.8B | $10.2B | $8.6B | |
| Property Plant And Equipment | $4.3B | $2.7B | $2.9B | $3.5B | $3.5B | |
| Long-Term Investments | $115M | $496M | $3.9B | $556M | $676M | |
| Goodwill | $7.7B | $13.9B | $14.5B | $18.1B | -- | |
| Other Intangibles | $2.9B | $6.6B | $6.3B | $10.4B | -- | |
| Other Long-Term Assets | $1.9B | $4.4B | $2.6B | $2.7B | -- | |
| Total Assets | $24.7B | $35.7B | $42.7B | $44.2B | $42B | |
| Accounts Payable | $2.1B | $1.3B | $1.3B | $1.3B | $1.4B | |
| Accrued Expenses | $3.3B | $3B | $3.2B | $3.9B | -- | |
| Current Portion Of Long-Term Debt | $538M | $516M | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | $1.3B | -- | -- | -- | |
| Total Current Liabilities | $6.2B | $7.8B | $5B | $5.7B | $9.8B | |
| Long-Term Debt | $6.2B | $8.6B | $8B | $7.7B | $8.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $14.8B | $19.4B | $16.1B | $16.7B | $21.7B | |
| Common Stock | $477M | $477M | $477M | $477M | $477M | |
| Other Common Equity Adj | -- | -$1.5B | -$1.3B | -$868M | -- | |
| Common Equity | $9.9B | $10.4B | $20.7B | $21.6B | $20.3B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $40M | $6B | $5.9B | $5.9B | $16M | |
| Total Equity | $9.9B | $16.3B | $26.6B | $27.5B | $20.3B | |
| Total Liabilities and Equity | $24.7B | $35.7B | $42.7B | $44.2B | $42B | |
| Cash and Short Terms | $2.4B | $1.8B | $8.1B | $3.6B | $1.5B | |
| Total Debt | $6.7B | $9.1B | $8.6B | $8.2B | $9.4B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $4.7B | $2.3B | $2.1B | $2.8B | $1.7B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2.7B | $2.2B | $2.8B | $2.7B | $3B | |
| Inventory | $2.3B | $2B | $2.4B | $2.2B | $2.4B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1.1B | $1.3B | $1.4B | $1.5B | -- | |
| Total Current Assets | $10.9B | $9B | $8.7B | $9.2B | $8.8B | |
| Property Plant And Equipment | $4.2B | $2.7B | $3.3B | $3.4B | $3.5B | |
| Long-Term Investments | $91M | $68M | $3.9B | $585M | $660M | |
| Goodwill | $7.7B | $14.1B | $18B | $17.9B | -- | |
| Other Intangibles | $2.8B | $6.5B | $11.3B | $10B | -- | |
| Other Long-Term Assets | $158M | $2.4B | $227M | $2.7B | -- | |
| Total Assets | $27B | $36.2B | $46.5B | $42.6B | $41.9B | |
| Accounts Payable | $2.1B | $1.2B | $1.2B | $1.3B | $1.3B | |
| Accrued Expenses | $1.6B | $1.4B | $1.2B | $3.6B | -- | |
| Current Portion Of Long-Term Debt | $37M | $1.8B | $3.2B | -- | -- | |
| Current Portion Of Capital Lease Obligations | $152M | $131M | $157M | -- | -- | |
| Other Current Liabilities | -- | $1.2B | -- | -- | -- | |
| Total Current Liabilities | $5.3B | $8.2B | $7.8B | $6B | $10.5B | |
| Long-Term Debt | $9.1B | $8.5B | $8.1B | $7B | $8.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $16.7B | $19.5B | $20B | $16.2B | $21.6B | |
| Common Stock | $477M | $477M | $477M | $477M | $477M | |
| Other Common Equity Adj | -- | -- | -$1.1B | -$1.3B | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $39M | $6B | $5.9B | $5.9B | $15M | |
| Total Equity | $10.3B | $16.7B | $26.6B | $26.4B | $20.3B | |
| Total Liabilities and Equity | $27B | $36.2B | $46.5B | $42.6B | $41.9B | |
| Cash and Short Terms | $4.7B | $2.3B | $2.1B | $2.8B | $1.7B | |
| Total Debt | $9.1B | $8.5B | $8.1B | $8.1B | $13.9B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.3B | $3.2B | $13.2B | $2B | $2.2B | |
| Depreciation & Amoritzation | $969M | $842M | $1.1B | $1.7B | $1.5B | |
| Stock-Based Compensation | $224M | $125M | $250M | $260M | $263M | |
| Change in Accounts Receivable | -$165M | -$143M | -$191M | -$99M | -$171M | |
| Change in Inventories | -$126M | -$334M | -$160M | $122M | -$1M | |
| Cash From Operations | $3.6B | $2.9B | $637M | $3.3B | $3.1B | |
| Capital Expenditures | $581M | $299M | $363M | $419M | $431M | |
| Cash Acquisitions | $1.6B | $5.7B | $705M | $8.3B | $7.3B | |
| Cash From Investing | -$2.1B | -$5.3B | $12.4B | -$5.4B | -$7.8B | |
| Dividends Paid (Ex Special Dividend) | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $71M | $5.4B | $395M | $322M | -- | |
| Long-Term Debt Repaid | -$883M | -$1.7B | -$3.6B | -$889M | -- | |
| Repurchase of Common Stock | $500M | $500M | $2.2B | $643M | $1.2B | |
| Other Financing Activities | $100M | $80M | -$169M | -$44M | -- | |
| Cash From Financing | -$2.4B | $2B | -$6.8B | -$2.5B | $2.7B | |
| Beginning Cash (CF) | $2.4B | $1.8B | $8.1B | $3.6B | $1.5B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$961M | -$550M | $6.2B | -$4.5B | -$2B | |
| Ending Cash (CF) | $1.4B | $1.1B | $14.3B | -$855M | -$539M | |
| Levered Free Cash Flow | $3B | $2.6B | $274M | $2.9B | $2.7B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $895M | $2.3B | $132M | $593M | $606M | |
| Depreciation & Amoritzation | $178M | $260M | $422M | $383M | $359M | |
| Stock-Based Compensation | $34M | $102M | $74M | $68M | $55M | |
| Change in Accounts Receivable | $172M | $78M | $94M | $156M | $119M | |
| Change in Inventories | -$177M | -$193M | -$97M | -$86M | -$141M | |
| Cash From Operations | $523M | $418M | $415M | $777M | $699M | |
| Capital Expenditures | $73M | $59M | $77M | $83M | $97M | |
| Cash Acquisitions | $39M | -- | $8.3B | $37M | -- | |
| Cash From Investing | $285M | $2.9B | -$8.5B | -$142M | -$125M | |
| Dividends Paid (Ex Special Dividend) | $307M | $306M | $300M | $301M | $312M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $3B | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$501M | -$9M | -- | -$2M | -- | |
| Repurchase of Common Stock | $253M | $2B | $247M | $899M | $250M | |
| Other Financing Activities | $22M | -$41M | -$45M | -$91M | -- | |
| Cash From Financing | $1.6B | -$2.9B | $2.1B | -$1.3B | -$364M | |
| Beginning Cash (CF) | $4.7B | $2.3B | $2.1B | $2.8B | $1.7B | |
| Foreign Exchange Rate Adjustment | -$37M | $58M | $7M | -$98M | -$6M | |
| Additions / Reductions | $2.4B | $467M | -$6B | -$754M | $204M | |
| Ending Cash (CF) | $7.1B | $2.8B | -$3.9B | $2B | $1.9B | |
| Levered Free Cash Flow | $450M | $359M | $338M | $694M | $602M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.8B | $4.7B | $11B | $2.4B | $2.3B | |
| Depreciation & Amoritzation | $903M | $924M | $1.2B | $1.7B | $1.5B | |
| Stock-Based Compensation | $194M | $193M | $222M | $254M | $250M | |
| Change in Accounts Receivable | -$225M | -$237M | -$175M | -$37M | -$208M | |
| Change in Inventories | -$266M | -$350M | -$64M | $133M | -$56M | |
| Cash From Operations | $3.3B | $2.8B | $634M | $3.7B | $3B | |
| Capital Expenditures | $532M | $285M | $381M | $425M | $445M | |
| Cash Acquisitions | $39M | $5.7B | $9B | $40M | $7.2B | |
| Cash From Investing | -$115M | -$2.7B | $1.1B | $3B | -$7.8B | |
| Dividends Paid (Ex Special Dividend) | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $3B | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$1.1B | -$1.2B | -$3.6B | -- | -- | |
| Repurchase of Common Stock | $740M | $2.2B | $461M | $1.3B | $594M | |
| Other Financing Activities | $80M | $17M | -$173M | -$90M | -- | |
| Cash From Financing | -$586M | -$2.4B | -$1.9B | -$5.8B | $3.7B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.5B | -$2.5B | -$195M | $758M | -$1.1B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $2.8B | $2.5B | $253M | $3.3B | $2.6B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $895M | $2.3B | $132M | $593M | $606M | |
| Depreciation & Amoritzation | $178M | $260M | $422M | $383M | $359M | |
| Stock-Based Compensation | $34M | $102M | $74M | $68M | $55M | |
| Change in Accounts Receivable | $172M | $78M | $94M | $156M | $119M | |
| Change in Inventories | -$177M | -$193M | -$97M | -$86M | -$141M | |
| Cash From Operations | $523M | $418M | $415M | $777M | $699M | |
| Capital Expenditures | $73M | $59M | $77M | $83M | $97M | |
| Cash Acquisitions | $39M | -- | $8.3B | $37M | -- | |
| Cash From Investing | $285M | $2.9B | -$8.5B | -$142M | -$125M | |
| Dividends Paid (Ex Special Dividend) | $307M | $306M | $300M | $301M | $312M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $3B | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$501M | -$9M | -- | -$2M | -- | |
| Repurchase of Common Stock | $253M | $2B | $247M | $899M | $250M | |
| Other Financing Activities | $22M | -$41M | -$45M | -$91M | -- | |
| Cash From Financing | $1.6B | -$2.9B | $2.1B | -$1.3B | -$364M | |
| Beginning Cash (CF) | $4.7B | $2.3B | $2.1B | $2.8B | $1.7B | |
| Foreign Exchange Rate Adjustment | -$37M | $58M | $7M | -$98M | -$6M | |
| Additions / Reductions | $2.4B | $467M | -$6B | -$754M | $204M | |
| Ending Cash (CF) | $7.1B | $2.8B | -$3.9B | $2B | $1.9B | |
| Levered Free Cash Flow | $450M | $359M | $338M | $694M | $602M | |
Related Companies
Get EMR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
EMR
Sector
P/E ratio
37.78x
20.30x
PEG ratio
2.09x
0.18x
P/B ratio
4.29x
1.80x
Price / LTM sales
4.81x
0.89x
Growth Metrics
EMR
Sector
Revenue growth
4.1%
4.57%
Earnings growth
4.71%
3.37%
Revenue (5-year growth)
1.41%
4.49%
Earnings forecast
$1.41
$0.33
Profitability
EMR
Sector
Profitability FY 2025
$8.6B
$243.7M
Return on invested capital
6.54%
4.52%
Return on assets
5.34%
3.1%
Return on equity
10.61%
7.99%
Earnings Date
Last Earnings Date
Feb
3
Next Earnings Date
May
6
Estimated Next Earnings Date
May
5
Balance Sheet
EMR
Sector
Total cash
$1.7B
$138.8M
Short term investments
--
$31.1M
Total assets
$42B
$1.4B
Long term debt
$13.9B
$44.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
40
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
91
TDC alert for Feb 12
Teradata Corp. [TDC] is down 11.64% over the past day.
Buy
67
DIOD alert for Feb 12
Diodes, Inc. [DIOD] is down 7.63% over the past day.
Buy
77
VRT alert for Feb 12
Vertiv Holdings Co. [VRT] is down 4.79% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
